Aptose Biosciences, Inc.
(Toronto Stock Exchange : APTO)

( )
APTO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 1.28%63.431.0%$435.37m
AMGNAmgen, Inc. -0.36%236.751.3%$418.05m
BIIBBiogen, Inc. 0.32%288.101.4%$366.81m
ILMNIllumina, Inc. 0.81%331.003.5%$323.28m
VRTXVertex Pharmaceuticals, Inc. 0.27%234.611.9%$274.89m
REGNRegeneron Pharmaceuticals, Inc. -1.26%359.142.6%$231.10m
EXASEXACT Sciences Corp. 10.55%94.9624.0%$230.33m
ALXNAlexion Pharmaceuticals, Inc. -1.43%111.402.0%$170.24m
INCYIncyte Corp. -0.22%78.482.5%$128.85m
AAgilent Technologies, Inc. 0.57%90.121.6%$124.56m
SRPTSarepta Therapeutics, Inc. -3.79%118.3314.6%$110.92m
BMRNBioMarin Pharmaceutical, Inc. 0.05%87.594.3%$106.70m
BLUEbluebird bio, Inc. -2.11%93.8014.2%$93.34m
SGENSeattle Genetics, Inc. 2.79%111.706.1%$92.29m
ITCIIntra-Cellular Therapies, Inc. 0.35%25.529.0%$86.96m

Company Profile

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.